145 related articles for article (PubMed ID: 21702731)
1. Delivery of cefotaxime to the brain via intranasal administration.
Manda P; Hargett JK; Vaka SR; Repka MA; Murthy SN
Drug Dev Ind Pharm; 2011 Nov; 37(11):1306-10. PubMed ID: 21702731
[TBL] [Abstract][Full Text] [Related]
2. Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake.
Vaka SR; Sammeta SM; Day LB; Murthy SN
J Pharm Sci; 2009 Oct; 98(10):3640-6. PubMed ID: 19156912
[TBL] [Abstract][Full Text] [Related]
3. Delivery of brain-derived neurotrophic factor via nose-to-brain pathway.
Vaka SR; Murthy SN; Balaji A; Repka MA
Pharm Res; 2012 Feb; 29(2):441-7. PubMed ID: 21879386
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid.
Vaka SRK; Murthy SN; Repka MA; Nagy T
J Pharm Sci; 2011 Aug; 100(8):3139-3145. PubMed ID: 21360710
[TBL] [Abstract][Full Text] [Related]
5. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
6. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
Bshara H; Osman R; Mansour S; El-Shamy Ael-H
Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
[TBL] [Abstract][Full Text] [Related]
7. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
8. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
[TBL] [Abstract][Full Text] [Related]
9. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
10. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Shah B; Khunt D; Misra M; Padh H
Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
[TBL] [Abstract][Full Text] [Related]
11. Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.
Arafat M; Kirchhoefer C; Mikov M
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):635-645. PubMed ID: 27686853
[TBL] [Abstract][Full Text] [Related]
12. Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration.
Wei Y; Ying M; Xu S; Wang F; Zou A; Cao S; Jiang X; Wang Y
Drug Deliv; 2016; 23(1):263-8. PubMed ID: 24865285
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
Shi S; Wu J; Dai W; Li C; Ge W
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
[TBL] [Abstract][Full Text] [Related]
14. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.
Perez AP; Mundiña-Weilenmann C; Romero EL; Morilla MJ
Int J Nanomedicine; 2012; 7():1373-85. PubMed ID: 22457595
[TBL] [Abstract][Full Text] [Related]
15. Brain distribution of ribavirin after intranasal administration.
Colombo G; Lorenzini L; Zironi E; Galligioni V; Sonvico F; Balducci AG; Pagliuca G; Giuliani A; Calzà L; Scagliarini A
Antiviral Res; 2011 Dec; 92(3):408-14. PubMed ID: 22001322
[TBL] [Abstract][Full Text] [Related]
16. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
Mei D; Mao S; Sun W; Wang Y; Kissel T
Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537
[TBL] [Abstract][Full Text] [Related]
17. Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain.
Manda P; Kushwaha AS; Kundu S; Shivakumar HN; Jo SB; Murthy SN
J Control Release; 2016 Feb; 224():69-76. PubMed ID: 26732557
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Shah B; Khunt D; Misra M; Padh H
Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil.
Vaka SR; Murthy SN
Pharmazie; 2010 Sep; 65(9):690-2. PubMed ID: 21038847
[TBL] [Abstract][Full Text] [Related]
20. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
